The test participants are patients with a condition, such as atopic dermatitis or asteatotic dermatitis, who presented with symptoms of inflammation and xerosis.
Conditions
Interventions
After 4 weeks of conditioning, for normal personal use, substitute the cleansing agent with the product of this study.
Sponsors
Kyusyu University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Progression of the underlying disease was slow; therefore, the attending physician considered the product to be useful in maintaining and improving skin condition. 2.Patient who can be medically examined at 4 and 8 weeks (a deviation of 1 week before or after is allowed) after the start of the study 3.Patient from whom written consent (consent from a legal guardian in case of minors) can be obtained. Further information about age and sex need not be asked.
Exclusion criteria
Exclusion criteria: 1.irritation or an allergic skin reaction because of the use of the product. 2.Patients with severe skin rashes such as contagious impetigo or Kaposi varicelliform eruption in the area where the product was used 3.Patients who cannot be medically examined at 4 and 8 weeks (as a general rule) after the start of the study 4.Patient whose participation in the study is deemed inappropriate by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of symptoms (erythema, papule, desquamation, xerosis, etc.) of the subject must not worsen, and the morphology and area of the stratum corneum (indicates the degree of cornification of the epidermal cells) | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin measurements were performed by using measuring devices and analyzing the horny cell layer by using tape-stripping method. Moisture content of the epidermal horny cell layer, amount of moisture loss through the skin, cytokines in the horny cell layer | — |
Countries
Japan
Contacts
Public ContactSatoshi Takeuchi
Kyusyu University Hospital Dermatology
Outcome results
None listed